Related Experiment Videos

Phosphatidylserine-mediated phagocytosis of anticancer drug-treated cells by macrophages

A Shiratsuchi1, Y Nakanishi

  • 1Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Ishikawa, 920-0934, Japan.

Journal of Biochemistry
|December 1, 1999
PubMed

Insights

Anticancer drugs trigger cancer cell apoptosis, leading to recognition and phagocytosis by immune cells. This process relies on phosphatidylserine externalization, a key signal for efficient clearance.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Apoptotic cells are typically cleared rapidly by phagocytes.
  • The mechanisms by which phagocytic cells recognize and engulf cancer cells undergoing drug-induced apoptosis are not fully understood.

Purpose of the Study:

  • To investigate the recognition and phagocytosis of cancer cells undergoing apoptosis induced by anticancer drugs.
  • To elucidate the role of phosphatidylserine externalization in this process.

Main Methods:

  • Human leukemia (Jurkat) cells were treated with doxorubicin or bufalin to induce apoptosis.
  • Apoptotic Jurkat cells were co-cultured with mouse peritoneal macrophages.
  • The effects of Z-VAD-FMK (a caspase inhibitor) and phosphatidylserine-containing liposomes on phagocytosis were assessed.

Main Results:

  • Anticancer drug treatment induced apoptosis and phosphatidylserine externalization in Jurkat cells.
  • Efficient phagocytosis of apoptotic Jurkat cells by macrophages was observed.
  • Both apoptosis and phagocytosis were inhibited by Z-VAD-FMK.
  • Phagocytosis was significantly reduced when phosphatidylserine-containing liposomes were present.

Conclusions:

  • Anticancer drugs induce apoptosis in cancer cells.
  • This apoptosis involves externalization of phosphatidylserine.
  • Phosphatidylserine serves as a signal for phagocytosis of these cancer cells by macrophages.
  • The findings suggest a mechanism for the clearance of drug-treated cancer cells.

Related Concept Videos